Gastric function in the elderly: Effects on absorption of ketoconazole

Journal of Clinical Pharmacology

Volumn 43, Issue 9, 2003, Pages 996-1002

  Hurwitz, Aryeh ^a   Ruhl, Constance E ^b   Kimler, Bruce F ^c   Topp, Elizabeth M ^e   Mayo, Matthew S ^c,d  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b Landon Center on Aging   (United States)

^c Department of Radiation Oncology ^*  (United States)

^d UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^e UNIVERSITY OF KANSAS   (United States)

Author keywords

Drug absorption; Elderly patients; Gastric function; Ketoconazole; Pharmacokinetics

Indexed keywords

ACID; KETOCONAZOLE; PENTETIC ACID; TECHNETIUM 99M;

AGED; AGING; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG HALF LIFE; FEMALE; FRUIT JUICE; GERIATRIC PATIENT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISOTOPE LABELING; MALE; NORMAL HUMAN; SCINTILLATION CAMERA; STOMACH ACID SECRETION; STOMACH EMPTYING; STOMACH FUNCTION; STOMACH PH; TABLET DISINTEGRATION; TELEMETRY;

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; FEMALE; GASTRIC ACID; GASTRIC ACIDITY DETERMINATION; GASTRIC EMPTYING; HUMANS; INTESTINAL ABSORPTION; KETOCONAZOLE; MALE; TABLETS;

EID: 0042513541     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/0091270003255645     Document Type: Article

References (51)

1. Williams L, Lowenthal DT: Drug therapy in the elderly. South Med J 1992;85:127-131.
2. Hämmerlein A, Derendorf H, Lowenthal DT: Pharmacokinetic and pharmacodynamic changes in the elderly: clinical implications. Clin Pharmacokinet 1998;35:49-64.
3. Carlson JA, Mann HJ, Canafax DM: Effect of pH on disintegration and dissolution of ketoconazole tablets. Am J Hospital Pharmacy 1983;40:1334-1336.
4. Hoeschele JD, Roy AK, Pecoraro VL, Carver PL: In vitro analysis of the interaction between sucralfate and ketoconazole. Antimicrob Agents Chemother 1994;38:319-325.
5. Chin TW, Loeb M, Fong IW. Effects of an acidic beverage (Coca-Cola) on absorption of ketoconazole. Antimicrob Agents Chemother 1995;39:1671-1675.
6. Blum RA, D'Andrea DT, Florentino BM, Wilton JH, Hilligoss DM, Gardner MJ, et al: Increased gastric pH and the bioavailability of fluconazole and ketoconazole. Ann Intern Med 1991;114:755-757.
7. Chutka DS, Evans JM, Fleming KC, Mikkelson KG: Symposium on geriatrics: Part I. Drug prescribing for elderly patients. Mayo Clin Proc 1995;70:685-693.
8. Hurwitz A, Brady DA, Schaal SE, Samloff IM, Dedon J, Ruhl CE: Gastric acidity in older adults. JAMA 1997;278:659-662.
9. Hurwitz A, Robinson RG, Vats TS, Whittier FC, Herrin WF: Effects of antacids on gastric emptying. Gastroenterology 1976;71:268-273.
10. Pascucci VL, Bennett J, Narang PK, Chatterji DC: Quantitation of ketoconazole in biological fluids using high-performance liquid chromatography. J Pharm Sci 1983;72:1467-1469.
11. Samloff IM: Pepsinogens I and II: purification from gastric mucosa and radioimmunoassay in serum. Gastroenterology 1982;82: 26-33.
12. Samloff IM, Varis K, Ihamaki T, Siurala M, Rotter JI: Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. Gastroenterology 1982;83:204-209.
13. Daniel WW: Applied Nonparametric Statistics. Boston: Houghton Mifflin, 1978.
14. Greenblatt DJ, Seller EM, Shader RI: Drug disposition in old age. N Engl J Med 1982;306:1081-1088.
15. Mayersohn MB: Special pharmacokinetic considerations in the elderly, in: Evans WE, Schentag JJ, Jusko WJ, Relling MV (eds.), Applied Pharmacokinetics: Principles of Therapeutic Drug Monitoring. 3rd ed. Vancouver, WA: Applied Therapeutics, 1992;9-1-9-39.
16. Dedichen L: Anacidity in old persons. Acta Med Scand 1924-1925; 61:345.
17. Goldschmiedt M, Feldman M: Age-related changes in gastric acid secretion, in: Holt PR, Russell RM (eds.), Chronic Gastritis and Hypochlorhydria in the Elderly. Boca Raton, FL: CRC Press, 1993; 13-29.
18. Piscitelli SC, Goss TF, Wilton JH, D'Andrea DT, Goldstein H, Schentag JJ: Effects of ranitidine and sucralfate on ketoconazole bioavailability. Antimicrob Agents Chemother 1991;35:1765-1771.
19. Russell TL, Berardi RR, Barnett JL, et al: Upper gastrointestinal pH in seventy-nine healthy, elderly, North American men and women. Pharm Res 1993;10:187-196.
20. Graybill JR: Is there a correlation between serum antifungal drug concentration and clinical outcome? J Infection 1994;28(Suppl. I):17-24.
21. van der Meer JWM, Keuning JJ, Scheijgrond HW, Heykants J, Van Cutsem J, Brugmans J: The influence of gastric acidity on the bio-availability of ketoconazole. J Antimicrob Chemother 1980;6:552-524.
22. Lelawongs P, Barne JA, Colaizzi JL, Hsuan ATM, Mechlinski W, Legendre R, et al: Effect of food and gastric acidity on absorption of orally administered ketoconazole. Clin Pharm 1988;7:228-235.
23. Lim SG, Sawyerr AM, Hudson M, Sercombe J, Pounder RE: Short report: the absorption of fluconazole and itraconazole under conditions of low intragastric acidity. Aliment Pharmacol Ther 1993;7: 317-321. Published erratum appears in Aliment Pharmacol Ther 1993;7:587.
24. Hann IM, Prentice HG, Keaney M, Corringham R, Blacklock HA, Fox J, et al: The pharmacokinetics of ketoconazole in severely immunocompromised patients. J Antimicrob Chemother 1982;10: 489-496.
25. Lake-Bakaar G, Tom W, Lake-Bakaar D, Gupta N, Beidas S, Elsakr M, et al: Gastropathy and ketoconazole malabsorption in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1988; 109:471-473.
26. Janssen Pharmaceutica: Nizoral: approved package circular. Titusville, NJ, 1997.
27. Charman WN, Porter CJH, Mithani S, Dressman JB: Physicochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. J Pharm Sci 1997;86:269-282.
28. Barr WH, Adir J, Garrettson L: Decrease of tetracycline absorption in man by sodium bicarbonate. Clin Pharmacol Ther 1971;12:779-784.
29. Sommers DEK, van Wyk M, Moncrieff J, Schoeman HS: Influence of food and reduced gastric acidity on the bioavailability of bacampicillin and cefuroxime axetil. Br J Clin Pharmacol 1984;18: 535-539.
30. Barr WH, Gerbracht LM, Letcher K, Plaut M, Strahl N: Assessment of the biologic availability of tetracycline products in man. Clin Pharmacol Ther 1972;13:97-108.
31. Hurwitz A: Antacid therapy and drug kinetics. Clin Pharmacokinet 1977;2:269-280.
32. Garty M, Hurwitz A: Effect of cimetidine and antacids on gastrointestinal absorption of tetracycline. Clin Pharmacol Ther 1980;28:203-207.
33. D'Arcy PF, McElnay JC: Drug-antacid interactions: assessment of clinical importance. Drug Intell Clin Pharm 1987;21:607-617.
34. Nimmo W, Prescott L: The influence of posture on paracetamol absorption. Br J Clin Pharmacol 1978;5:157-168.
35. Amidon GL, DeBrincat GA, Najib N: Effects of gravity on gastric emptying, intestinal transit, and drug absorption. J Clin Pharmacol 1991;31:968-973.
36. Hunt JN, Knox MT: The slowing of gastric emptying by four strong acids and three weak acids. J Physiol (Lond) 1972;22:187-208.
37. Ameer B, Weintraub RA: Drug interactions with grapefruit juice. Clin Pharmacokinet 1997;33:103-121.
38. Bailey DG, Malcolm J, Arnold O, Spence JD: Grapefruit juice-drug interactions. Br J Clin Pharmacol 1998;46:101-110.
39. Kane GC, Lipsky JJ: Drug-grapefruit juice interactions. Mayo Clin Proc 2000;75:933-942.
40. Malhotra S, Bailey DG, Paine MF, Watkins PB: Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of furocoumarins. Clin Pharmacol Ther 2001;69: 14-23.
41. Kawakami M, Suzuki K, Ishizuka T, Hidaka T, Matsuki Y, Nakamura H: Effect of grapefruit juice on pharmacokinetics of itraconazole in healthy subjects. Int J Clin Pharmacol Ther 1998;36: 306-308.
42. Penzak SR, Gubbins PO, Gurley BJ, Wang PL, Saccente M: Grape-fruit juice decreases the systemic availability of itraconazole capsules in healthy volunteers. Ther Drug Monit 1999;21:304-309.
43. Daneshmend TK, Warnock DW: Clinical pharmacokinetics of ketoconazole. Clin Pharmacokinet 1988;14:13-34.
44. Collen MJ, Abdulian JD, Chen YK: Age does not affect basal gastric acid secretion in normal subjects or in patients with acid-peptic disease. Am J Gastroenterol 1994;89:712-716.
45. Feldman M, Cryer B, McArthur KE, Huet BA, Lee E: Effects of aging and gastritis on gastric acid and pepsin secretion in humans: a prospective study. Gastroenterology 1996;110:1043-1052.
46. Hall KE, Wiley JW: Age-associated changes in gastrointestinal function, in: Hazzard WR, Blass JP, Ettinger WH, Halter JB, Ouslander JG (eds.), Principles of Geriatric Medicine and Gerontology. 4th ed. New York: McGraw-Hill, 1999;835-842.
47. Drew RH, Perfect JR, Gallis HA: Use of fluconazole in a patient with documented malabsorption of ketoconazole. Clin Pharm 1988;7:622-623.
48. Baciewicz AM, Baciewicz FA: Ketoconazole and fluconazole drug interactions. Arch Intern Med 1993;153:1970-1976.
49. Cooper JK, Love DW, Raffoul PR: Intentional prescription nonadherence (noncompliance) by the elderly. J Am Geriatr Soc 1982;30:329-333.
50. Col N, Fanale JE, Kronholm P: The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990;150:841-845.
51. Salzman C: Medication compliance in the elderly. J Clin Psychiatry 1995;56(Suppl. 1):18-22.